University of Turku   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Turku Finland (1920)

Organization Overview

First Clinical Trial
1994
NCT00966264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Anselm Tamminen | Assoc. Prof., University of Turku | CRST, Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland | Department of Child Psychiatry, Turku University Hospital, Kiinamyllynkatu 4-8, PL 52, 20521 Turku, Finland Department of Child Psychiatry and Finn Brain, University of Turku, 20014 Turku, Finland | Department of Oncology and Radiotherapy, Turku University Hospital | Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland | Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland | Department of surgery, Turku University Hospital | Dept. Anaesthesiology and Intensive Care, University Of Turku | Dept of Oncology, Turku University Hospital, Finland | Dept of Pediatrics, Turku University Hospital, Turku, Finland. | Heart Center, Turku University, Finland | Heart Center, Turku University Hospital and University of Turku, Turku, Finland | Hospital District of Southwestern Finland | Hospital District of the South-West Finland | Jarmo Oksi | Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital | Perioperative Services, Intensive Care Medicine and Pain Management; Turku University Hospital | PET centre, Turku | Petri Vainio | Research Support, Turku University Hospital, Turku, Finland | Shiny Horse Ltd | Terveystalo Turku, Finland | Tours Universiity Hospital | Turku Hospital | Turku PET Centre | Turku PET Centre, Turku, Finland | Turku PET Centre, Turku University Hospital, Turku, Finland | Turku PET Centre, University of Turku, Turku, Finland | Turku UH | Turku University | Turku University Central Hospital (co-sponsor, Finland) | Turku University Central Hospital, Department of Neurosurgery | Turku University Hospital | Turku University Hospital and Turku University | Turku University Hospital and University of Turku, Turku , Finland | Turku University Hospital, Department of Oncology and Radiotherapy, Savitehtaankatu 1, FIN-20520 Turku, Finland | Turku University Hospital, Hospital District of Southwest Finland | Turku University Hospital, Turku, Finland | Turku University Hospital, Turku PET Centre | Turku University Hospital, University of Turku | Turku University, Turku University Hospital | Turun Gynekologikeskus, Turku, Finland | University of Turku | University of Turku, Department of Pediatrics | University of Turku, Institute of Dentistry | University of Turku, Turku, Finland | University of Turku, Turku, Finland, The Research Centre of Applied and Preventive Cardiovascular Medicine | University of Turku, Turku University Hospital

Active Ingredients

Drugs in Phase 4 Trials (54)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

acellular pertussis vaccine (1 trial)

acetylsalicylic acid (aspirin) (1 trial)

bifidobacterium animalis (4 trials)

boostrix (2 trials)

bupivacaine (Exparel) (1 trial)

buprenorphine (1 trial)

ceftriaxone (rocephin) (1 trial)

clavulanate (Augmentin) (1 trial)

collagenase clostridium histolyticum (xiaflex) (1 trial)

dapagliflozin (farxiga) (2 trials)

denosumab (prolia) (1 trial)

dexamethasone (1 trial)

dexmedetomidine (precedex) (10 trials)

doxycycline (vibramycin) (1 trial)

duloxetine (Cymbalta) (2 trials)

edoxaban (savaysa) (2 trials)

enoxaparin (lovenox) (1 trial)

escherichia coli nissle 1917 (1 trial)

fentanyl (Innovar) (2 trials)

ferric carboxymaltose (Injectafer) (1 trial)

follitropin alfa (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

infliximab (remicade) (1 trial)

insulin human (humulin) (5 trials)

itraconazole (sporanox) (1 trial)

ketamine (ketalar) (4 trials)

lutropin alpha (luveris) (1 trial)

metformin (glucophage) (1 trial)

milk protein (1 trial)

naltrexone (revia) (2 trials)

oseltamivir (tamiflu) (1 trial)

oxycodone (oxycontin) (5 trials)

oxytocin (syntocinon) (1 trial)

prednisone (meticorten) (3 trials)

pregabalin (lyrica) (2 trials)

procaine benzylpenicillin (novocaine) (1 trial)

propofol (diprivan) (3 trials)

rifampin (1 trial)

ropivacaine (naropin) (1 trial)

semaglutide (Ozempic) (1 trial)

sevoflurane (ultane) (1 trial)

sitagliptin (januvia) (4 trials)

sulfasalazine (azulfidine) (2 trials)

tetanus toxoid (1 trial)

ticlopidine (ticlid) (1 trial)

tramadol (Ultram) (1 trial)

triptorelin (Trelstar) (1 trial)

venlafaxine (effexor) (1 trial)

vitamin d3 (2 trials)

warfarin (coumadin) (1 trial)

whole-cell pertussis vaccine (1 trial)

xylitol (3 trials)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 3 Trials (24)

agalsidase alfa (Replagal) (2 trials)

atorvastatin (lipitor) (1 trial)

bacille calmette-guerin (1 trial)

bortezomib (velcade) (2 trials)

dinoprost (1 trial)

dotanoc (1 trial)

epirubicin (ellence) (2 trials)

erythritol (1 trial)

ga-68-dota-toc (Ga-68-dota-toc) (1 trial)

grazax (1 trial)

letrozole (femara) (1 trial)

live attenuated influenza virus vaccine (flumist) (1 trial)

medroxyprogesterone (provera) (1 trial)

mitomycin (mutamycin) (2 trials)

norgestrel (Ovral) (1 trial)

p. pratense pollen extract (1 trial)

secretin human (chirhostim) (1 trial)

s-methionine (1 trial)

sorbitol (2 trials)

sulfur hexafluoride lipid-type a microspheres (Lumason) (1 trial)

testosterone (delatestryl) (1 trial)

tocilizumab (actemra) (1 trial)

urea (2 trials)

ursodeoxycholic acid (1 trial)

Drugs in Phase 2 Trials (38)

anakinra (kineret) (1 trial)

ancestim (1 trial)

azathioprine (imuran) (1 trial)

azd8601 (1 trial)

bendamustine (treanda) (1 trial)

bevacizumab (avastin) (2 trials)

bexmarilimab (1 trial)

cabazitaxel (jevtana kit) (1 trial)

capecitabine (xeloda) (1 trial)

carbidopa (sinemet) (1 trial)

catechin (1 trial)

celecoxib (celebrex) (2 trials)

cellulose (1 trial)

cyclophosphamide (cytoxan) (2 trials)

dacarbazine (dtic-dome) (1 trial)

docetaxel (taxotere) (3 trials)

dopamine (intropin) (1 trial)

ef5 (1 trial)

entacapone (comtan) (1 trial)

etoposide (vepesid) (1 trial)

fish oil (Omegavan) (1 trial)

ibandronate (boniva) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

interferon beta-1b (betaseron) (1 trial)

lactobacillus delbrueckii (2 trials)

leflunomide (arava) (1 trial)

levosimendan (1 trial)

liraglutide (victoza) (5 trials)

oxygen (1 trial)

probiotic (3 trials)

rituximab (rituxan) (1 trial)

ropinirole (Requip) (1 trial)

sargramostim (leukine) (2 trials)

sodium chloride (2 trials)

sodium phosphate (1 trial)

thalidomide (Thalomid) (1 trial)

xenon-129 (1 trial)

xenon xe-133 (1 trial)

Drugs in Phase 1 Trials (21)

atipamezole (1 trial)

atomoxetine (strattera) (2 trials)

caffeine (1 trial)

cis-urocanic acid (1 trial)

clarithromycin (biaxin) (1 trial)

dabigatran (pradaxa) (2 trials)

diclofenac (voltaren) (1 trial)

esomeprazole (nexium) (1 trial)

gip (1-42) (1 trial)

lactobacillus rhamnosus (2 trials)

mesalamine (rowasa) (1 trial)

metoprolol (lopressor) (1 trial)

midazolam (versed) (1 trial)

morphine (2 trials)

orm-12741 (1 trial)

orm-13070 (1 trial)

peginterferon beta-1a (Plegridy) (1 trial)

posaconazole (noxafil) (1 trial)

torcoxia (1 trial)

voriconazole (vfend) (2 trials)

zopiclone (1 trial)

Drugs in Other Trials (29)

adenosine (Adenocard) (1 trial)

apixaban (eliquis) (1 trial)

azithromycin (zithromax) (1 trial)

bilberry (1 trial)

cefuroxime (zinacef) (1 trial)

cow milk (1 trial)

dimethyl sulfoxide (rimso) (2 trials)

egg (1 trial)

ertapenem (invanz) (4 trials)

ethanol (1 trial)

fludeoxyglucose f-18 (1 trial)

fluorouracil (efudex) (1 trial)

fluoxetine (prozac) (1 trial)

ga-dota-siglec-9 (1 trial)

galactooligosaccharide (1 trial)

glucose (1 trial)

human fecal microbiota (Reybota) (3 trials)

inulin (1 trial)

levobupivacaine (chirocaine) (1 trial)

levofloxacin (levaquin) (1 trial)

metronidazole (flagyl) (1 trial)

moxifloxacin (avelox) (2 trials)

platelets (1 trial)

Potassium Hydrogen Carbonate (1 trial)

prulifloxacin (4 trials)

rivaroxaban (xarelto) (1 trial)

Silibinin (1 trial)

sunitinib (sutent) (1 trial)

xanthophyll (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Spontaneous (Phase 3)

Adenomyosis (Phase 4)

Agammaglobulinemia (Phase 2)

Alcohol Drinking (Phase 1)

Anemia, Hemolytic (Phase 2)

Anemia, Hemolytic, Autoimmune (Phase 2)

Aneurysm (Phase 4)

Aortic Aneurysm (Phase 4)

Aortic Aneurysm, Thoracic (Phase 4)

Aortic Valve Stenosis (Phase 4)

Apnea (Phase 3)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 2)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 4)

Bacterial Infections (Phase 2)

Blood Coagulation Disorders (Phase 4)

Brain Injuries (Phase 2)

Brain Ischemia (Phase 2)

Breast Neoplasms (Phase 2)

Cerebral Hemorrhage (Phase 4)

Cholestasis (Phase 3)

Cholestasis, Intrahepatic (Phase 3)

Common Variable Immunodeficiency (Phase 2)

Communicable Diseases (Phase 4)

Consciousness Disorders (Phase 4)

Contracture (Phase 4)

Coronary Artery Disease (Phase 4)

Critical Illness (Phase 4)

Dental Caries (Phase 4)

Dental Plaque (Phase 2)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Diabetes, Gestational (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 4)

Dupuytren Contracture (Phase 4)

Eczema (Phase 4)

Embolism (Phase 4)

Epilepsies, Myoclonic (Phase 2)

Epilepsy (Phase 2)

Fabry Disease (Phase 3)

Glioma (Phase 3)

Granuloma (Phase 3)

Head and Neck Neoplasms (Phase 2)

Heart Arrest (Phase 2)

Heart Failure (Phase 2)

Hemolysis (Phase 2)

Hemorrhage (Phase 4)

Hemostatic Disorders (Phase 4)

Hypertension (Phase 2)

Hypothermia (Phase 2)

Infections (Phase 4)

Infertility (Phase 4)

Inflammation (Phase 4)

Influenza, Human (Phase 4)

Insulin Resistance (Phase 4)

Ischemia (Phase 2)

Ischemic Attack, Transient (Phase 2)

Leiomyoma (Phase 4)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)

Lyme Neuroborreliosis (Phase 4)

Lymphoma (Phase 2)

Melanoma (Phase 2)

Menorrhagia (Phase 3)

Mucositis (Phase 2)

Multiple Myeloma (Phase 3)

Multiple Organ Failure (Phase 2)

Multiple Sclerosis (Phase 4)

Myoclonic Epilepsies, Progressive (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neuralgia (Phase 4)

Neuralgia, Postherpetic (Phase 4)

Obesity (Phase 1)

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 4)

Otitis (Phase 4)

Otitis Media (Phase 4)

Pain, Postoperative (Phase 4)

Pain, Procedural (Phase 4)

Parkinson Disease (Phase 2)

Polycystic Ovary Syndrome (Phase 3)

Polyneuropathies (Phase 4)

Postoperative Complications (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Pregnancy in Diabetics (Phase 4)

Prostatic Neoplasms (Phase 3)

Respiratory Sounds (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Sarcoidosis (Phase 3)

Sarcoidosis, Pulmonary (Phase 3)

Sclerosis (Phase 4)

Scoliosis (Phase 4)

Sleep Apnea Syndromes (Phase 3)

Spondylolisthesis (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Still's Disease, Adult-Onset (Phase 2)

Stomach Neoplasms (Phase 2)

Stomatitis (Phase 2)

Stroke (Phase 2)

Subarachnoid Hemorrhage (Phase 2)

Syndrome (Phase 3)

Tennis Elbow (Phase 4)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Toxemia (Phase 3)

Unconsciousness (Phase 4)

Unverricht-Lundborg Syndrome (Phase 2)

Urinary Bladder Neoplasms (Phase 3)

Urinary Tract Infections (Phase 4)

Venous Thromboembolism (Phase 4)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 150
  • # of Trial APIs: 166